Enveric Biosciences (ENVB) EBITDA Margin Growth (3y) (2017 - 2020)
Enveric Biosciences (ENVB) EBITDA Margin Growth (3y) (2017 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | -2,649.00 |
| 10 | Enveric Biosciences | 5.72 Mn | -2.57 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 2,571.00 |
| Jun 30, 2020 | 1,930.00 |
| Mar 31, 2020 | -360.00 |
| Dec 31, 2019 | 4,006.00 |
| Sep 30, 2019 | -426.00 |
| Jun 30, 2019 | 60.00 |
| Mar 31, 2019 | 184.00 |
| Dec 31, 2018 | -8,215.00 |
| Sep 30, 2018 | 6,475.00 |
| Jun 30, 2018 | -1,432.00 |
| Mar 31, 2018 | -3,748.00 |
| Jun 30, 2017 | -4,300.00 |